This new alternative to CPAP was created by Inspire Medical Systems and approved by the Food and Drug Administration (FDA), is an implanted device.
Depending on the degree of severity, OSA can be a potentially life-threatening condition. Even in mild cases the related sleepiness can increase the risk of fatigue-related car accidents.
For several years research shows that a person with poorly managed sleep apnea is at increased risk for heart attack, stroke, weight gain, high blood pressure and heart failure.
While CPAP is often successful, studies show that roughly half of all patients that start CPAP eventually become non-compliant.
In contrast to CPAP, Inspire therapy works from inside the body and with a patient’s natural breathing process.
The implantable system includes a small generator, a sensing lead and a stimulation lead. Turned on by a handheld remote, it delivers mild stimulation to key airway muscles, which keeps the airway open during sleep.
In cases where the simulator by itself is not fully effective combination of treatments may be attempted.
In a recent published case study, the combination of 2 different OSA treatments: a mandibular advancement device and the inspire were used together to improve overall treatment response.
The article, Severe Obstructive Sleep Apnea Treated with Combination Hypoglossal Nerve Stimulation and Oral Appliance Therapy, was published in the Journal of Dental Sleep Medicine.